Fifteen-year-old Carlo Acutis died within a week of being diagnosed with acute promyelocytic leukemia. Following his ...

Anti-inflammatory 25(OH)D 3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia Differentiation syndrome (DS) is a ...

CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company specializing in developing transformative treatments for rare diseases, announced the initiation of a ...

Acute promyelocytic leukemia (APL) was once among the most feared diagnoses in hematology, with patients routinely dying ...

Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...

Anti-tumor activity of CoREST inhibitor, JBI-802 (dual epigenetic modifier of LSD1/HDAC6): An opportunity to treat essential thrombocythemia and MPN/MDS patients with thrombocytosis in ongoing phase 1 ...

In a phase 3 trial of 133 patients with high-risk acute promyelocytic leukemia (APL), all-trans retinoic acid and arsenic trioxide (ATRA-ATO) therapy demonstrated superior 2-year event-free survival ...

Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...

Please provide your email address to receive an email when new articles are posted on . All patients who received the oral regimen achieved an initial complete remission. Survival rates remain more ...

A 28-year-old woman who was prescribed antibiotics for tonsillitis was diagnosed with a rare form of leukemia after ...